APA

Mamlouk K., Saracino G., Berryman R. B., Fay J. W., Pineiro L. A., Vance E. A., White M., Sandler I. & Agura E. D. (20050728). Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring. : Bone marrow transplantation.

Chicago

Mamlouk K, Saracino G, Berryman R B, Fay J W, Pineiro L A, Vance E A, White M, Sandler I and Agura E D. 20050728. Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring. : Bone marrow transplantation.

Harvard

Mamlouk K., Saracino G., Berryman R. B., Fay J. W., Pineiro L. A., Vance E. A., White M., Sandler I. and Agura E. D. (20050728). Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring. : Bone marrow transplantation.

MLA

Mamlouk K, Saracino G, Berryman R B, Fay J W, Pineiro L A, Vance E A, White M, Sandler I and Agura E D. Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring. : Bone marrow transplantation. 20050728.